| |

Bortezomib

Bortezomib Suppliers list
Company Name:Nanjing Norris-Pharm Technology Co., Ltd  Gold
Tel:+86-25-66112881 +86-25-66112885
Email:sales@norris-pharm.com
Products Intro: CAS:179324-69-7
Purity:97% HPLC Package:1g;5g;25g;100g;500g;5kg;25kg
Company Name:MedChemexpress LLC  Gold
Tel:609-228-6898
Email:sales@medchemexpress.cn
Products Intro: Product Name:Bortezomib
CAS:179324-69-7
Purity:>98% Package:10mg;50mg;100mg;
Company Name:Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd  Gold
Tel:010-64430626/13801208576
Email:maggie@chinazhongshuo.com
Products Intro: Product Name:Bortezomib
CAS:179324-69-7
Company Name:Wuhan Biocar Bio-Pharm Co., Ltd.  Gold
Tel:15377519203
Email:newbio@biocar.cn
Products Intro: Product Name:Bortezomib
CAS:179324-69-7
Purity:99% Package:1g;10g;50g
Company Name:Mascot I.E. Co., Ltd  Gold
Tel:+86-519-85010339/362/319
Email:info@mascot-ie.com
Products Intro: Product Name:BortezoMib
CAS:179324-69-7
Purity:98% Package:1KG;10KG;100KG
Bortezomib Basic information
Product Name:Bortezomib
Synonyms:VELCADE;dpba;BORTEZOMIB;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Bortezomib for research;Bortezomib ( Velcade, MG-341, PS-341 )
CAS:179324-69-7
MF:C19H25BN4O4
MW:384.24
EINECS:
Product Categories:Boron Derivatives;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Pepetides;ProteasomeInhibitors;Apis;Inhibitor;Final material;API;peptides
Mol File:179324-69-7.mol
Bortezomib Structure
Bortezomib Chemical Properties
mp 122-124°C
density 1.214
storage temp. Hygroscopic, -20°C Freezer, Under Inert Atmosphere
Stability:Hygroscopic and Moisture Sensitive
CAS DataBase Reference179324-69-7(CAS DataBase Reference)
Safety Information
Hazardous Substances Data179324-69-7(Hazardous Substances Data)
MSDS Information
Bortezomib Usage And Synthesis
Chemical PropertiesYellow Solid
UsageBortezomib is the first proteasome inhibitor to be approved b the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. T
UsageBortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle foun d in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
Usageselective proteasome inhibitor
Bortezomib Preparation Products And Raw materials
Tag:Bortezomib(179324-69-7) Related Product Information
Bortezomib Bensulfuron methyl tert-Butylchlorodiphenylsilane EC 2.6.1.2 (4R)-4-[[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one Propyl butyrate 3,4'-DIAMINODIPHENYLMETHANE Birch-Me Propyl gallate Methyl Kresoxim-methyl Thiophanate-methyl Glucosamine Phenylacetone ACETAMINOPHENOL BP/USP Methyl bromide Isopropanol PHENYL VALERATE